References
- Rosengarten D, Blieden LC, Kramer MR. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J. 2012;40(5):1304–1305.
- Shenoy V, Qi Y, Katovich MJ, et al. ACE2, a promising therapeutic target for pulmonary hypertension. Curr Opin Pharmacol. 2011;11(2):150–155.
- Zhuo JL, Ferrao FM, Zheng Y, et al. New frontiers in the intrarenal renin-angiotensin system: a critical review of classical and new paradigms. Front Endocrinol (Lausanne). 2013;4:166.
- Yuan P, Wu WH, Gao L, et al. Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin pathways. Eur Respir J. 2013;41(5):1116–1125.
- Tofovic SP. Estrogens and development of pulmonary hypertension: interaction estradiol metabolism and pulmonary vascular disease. Cardiovasc Pharmacol. 2010;56(6):696–708.
- Oshima T, Nakajima S, Yokoyama T, et al. The g protein beta3 subunit 825 TT genotype is associated with epigastric pain syndrome-like dyspepsia. BMC Med Genet. 2012;17:11–13.
- Ventetuolo CE, Praestgaard A, Palevsky HI, et al. Sex and haemodynamics in pulmonary arterial hypertension. Eur Respir J. 2014;43(2):523–530.
- Queiros AM, Eschen C, Fliegner D, et al. Sex-and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heart. Int J Cardiol. 2013;169(5):331–338.
- Kararigas G, Fliegner D, Gustafsson JA, et al. Role of the estrogen/estrogen-receptor-beta axis in the genomic response to pressure overload-induced hypertrophy. Physiol Genomics. 2011;43(8):438–446.
- Dumas-de La Roque E, Bellance N, Rossignol R, et al. Dehydroepiandrosterone reverses chronic hypoxia/reoxygenation-induced right ventricular dysfunction in rats. Eur Respir J. 2012;40(6):1420–1429.
- Iorga A, Dewey S, Partow-Navid R, et al. Pregnancy is associated with decreased cardiac proteasome activity and oxidative stress in mice. PLoS One. 2012;7(11):e48601.
- Hemnes AR, Kiely DG, Cockrill BA, et al. Statement on pregnancy in pulmonary hypertension from the pulmonary vascular research institute pulmonary. Circulation. 2015;5:435–465.
- Cordina RL, Celermajer DS. Therapeutic approaches in adults with congenital heart disease associated pulmonary arterial hypertension. Eur Respir Rev. 2010;19(118):300–307.
- De Man FS, Tu L, Handoko ML, et al. Dysregulated renin–angiotensin–aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186(8):780–789.
- William LB, William BW. Azilsartan medoxomil: a new angiotensin II receptor antagonist for treatment of hypertension. Ann Pharmacother. 2011;45(12):1506–1515.
- Bradford CN, Ely DR, Raizada MK. Targeting the vasoprotective axis of the renin-angiotensin system: a novel strategic approach to pulmonary hypertensive therapy. Curr Hypertens Rep. 2010;12(4):212–219.
- Lumbers ER, Pringle KG. Roles of the circulating renin-angiotensin-aldosterone system in human pregnancy. Am J Physiol Regul Integr Comp Physiol. 2014;306(2):R91–101.
- Xue B, Johnson AK, Hay M. Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen. Am J Physiol Regul Integr Comp Physiol. 2013;305(5):R459–63.
- Duarte AG, Thomas S, Safdar Z, et al. Management of pulmonary arterial hypertension during pregnancy: a retrospective, multicenter experience. Chest. 2013;143(5):1330–1336.
- Ali§N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society(ERS), endowed hy the International Society of Heart and Lung Transplantation(1SHLT). Eur Heart J. 2009;30:2493–2537.
- Iely DG, Condliffe R, Webster V, et al. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach. Bjog. 2010;117:565–574.
- Yang XP, Reckelhoff JF. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens. 2011;20:133–138.